person

Malek B.

Country
Germany
Department
Psychiatrie und Psychotherapie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 4 partner sites.

Specializations

Psychotic Disorders

Focus on severe mental illnesses characterized by loss of reality testing, including early‑onset and treatment‑resistant forms such as Schizophrenia and acute psychotic episodes.

  • Schizophrenia
  • Acute psychosis
  • Treatment‑resistant psychosis

Collaborative studies at Charité integrate neuroimaging and biomarker profiling to refine diagnostic precision.

Mood and Affective Disorders

Investigation of depressive and bipolar spectrum conditions, with emphasis on comorbid attention‑deficit hyperactivity disorder and treatment‑resistant depression.

  • Major Depressive Disorder
  • Treatment‑Resistant Depression
  • ADHD with moderate to severe depression

Research includes evaluation of novel psychotherapeutic interventions and digital health tools for symptom monitoring.

Anxiety and Stress‑Related Disorders

Clinical work on anxiety, panic, and trauma‑related conditions, targeting both adult and adolescent populations, including Generalized Anxiety Disorder and Post‑Traumatic Stress Disorder.

  • Generalized Anxiety Disorder
  • Post‑Traumatic Stress Disorder
  • Panic disorder

Studies incorporate physiological stress markers and outcomes of cognitive‑behavioral therapy.

Neurocognitive and Dementia Disorders

Research on progressive cognitive decline, including early‑stage Alzheimer’s disease, mild cognitive impairment, and vascular dementia.

  • Alzheimer’s Disease
  • Mild Cognitive Impairment
  • Vascular Dementia

Projects explore disease‑modifying agents and longitudinal neuropsychological assessments.

Neuroimmunological Conditions

Exploration of autoimmune‑mediated neurological diseases that intersect psychiatry and neurology, such as autoimmune encephalitis, Myasthenia Gravis, and ANCA‑associated vasculitis with neurological involvement.

  • Autoimmune encephalitis
  • Myasthenia Gravis
  • ANCA‑associated vasculitis

Integration of immunomodulatory therapies with psychiatric care pathways aims to improve functional outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.